Harbour BioMed Leverages PPD’s Biotech to Develop Innovative Therapeutics


Applied Clinical Trials

Harbour BioMed and Pharmaceutical Product Development, LLC have announced that HBM will use the services of PPD’s Biotech to develop innovative therapeutics in the areas of oncology and immunology.

To learn more, click here. 

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.